Neurotensin stimulates polyphosphoinositide breakdown and prolactin release in anterior pituitary cells in culture

[1]  W. Malaisse,et al.  Nutrient and hormone-neurotransmitter stimuli induce hydrolysis of polyphosphoinositides in rat pancreatic islets. , 1984, Endocrinology.

[2]  M. Gershengorn,et al.  Inositol trisphosphate mediates thyrotropin-releasing hormone mobilization of nonmitochondrial calcium in rat mammotropic pituitary cells. , 1984, The Journal of biological chemistry.

[3]  A. H. Drummond,et al.  Thyrotropin-releasing hormone-stimulated [3H]inositol metabolism in GH3 pituitary tumor cells. Studies with lithium. , 1984, Molecular pharmacology.

[4]  T. Martin.  Thyrotropin-releasing hormone rapidly activates the phosphodiester hydrolysis of polyphosphoinositides in GH3 pituitary cells. Evidence for the role of a polyphosphoinositide-specific phospholipase C in hormone action. , 1983, The Journal of biological chemistry.

[5]  R. Wojcikiewicz,et al.  Thyrotropin-releasing hormone stimulates inositol phosphate production in normal anterior pituitary cells and GH3 tumour cells in the presence of lithium , 1983, Bioscience reports.

[6]  M. Berridge.  Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. , 1983, The Biochemical journal.

[7]  M. Berridge,et al.  Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. , 1983, The Biochemical journal.

[8]  C. Downes.  Receptor-stimulated inositol phospholipid metabolism in the central nervous system. , 1982, Cell calcium.

[9]  C. Kirk.  Ligand-stimulated inositol lipid metabolism in the liver: relationship to receptor function. , 1982, Cell calcium.

[10]  A. Rogol,et al.  Selective growth hormone and cyclic AMP stimulating activity is present in human pancreatic islet cell tumor. , 1982, The Journal of clinical endocrinology and metabolism.

[11]  C. Granier,et al.  Synthesis and Characterization of Neurotensin Analogues for Structure/Activity Relationship Studies , 1982 .

[12]  A. Enjalbert,et al.  Neurotensin stimulation of prolactin secretion in vitro. , 1982, Neuroendocrinology.

[13]  K. Wirtz,et al.  Corticotropin-(1--24)-tetracosapeptide affects protein phosphorylation and polyphosphoinositide metabolism in rat brain. , 1981, The Biochemical journal.

[14]  J. Schacht.  Extraction and purification of polyphosphoinositides. , 1981, Methods in enzymology.

[15]  R. Quirion,et al.  Selective blockade of neurotensin-induced coronary vessel constriction in perfused rat hearts by a neurotensin analogue. , 1980, European journal of pharmacology.

[16]  L. Frohman,et al.  Dissociation of systemic and central effects of neurotensin on the secretion of growth hormone, prolactin, and thyrotropin. , 1978, Endocrinology.

[17]  J. Rivier,et al.  NEUROTENSIN ANALOGS. STRUCTURE-ACTIVITY RELATIONSHIPS , 1978 .

[18]  J. Rivier,et al.  Neurotensin analogues. Structure--activity relationships. , 1977, Journal of medicinal chemistry.

[19]  W. Vale,et al.  Regional distribution of neurotensin and somatostatin in rat brain , 1977, Brain Research.

[20]  W. Vale,et al.  Effect of neurotensin, substance P and morphine sulfate on the secretion of prolactin and growth hormone in the rat. , 1977, Endocrinology.

[21]  G. Uhl,et al.  Regional and subcellular distributions of brain neurotensin. , 1976, Life sciences.